Reports for GLICLAZIDE
Ingredient
GLICLAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2022-12-16 | 2022-12-23 | 178760 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2023-04-21 | 2023-06-29 | 189988 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-01-26 | 2024-03-15 | 217487 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-03-01 | 2024-03-15 | 221093 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-11-26 | 2020-12-17 | 128933 |
| APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-10-06 | 2024-02-16 | 206563 |
| APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-01-26 | 2023-02-23 | 182382 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-29 | 2020-07-30 | 121325 |
| APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-01-30 | 2025-03-28 | 249074 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-21 | 2018-03-21 | 29960 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| DIAMICRON | 80MG | TABLET | Discontinued | 2022-08-31 | 2022-10-03 | 168298 |
| GLICLAZIDE-80 | 80MG | TABLET | Discontinued | 2021-03-29 | 2021-03-30 | 136513 |
| MYLAN-GLICLAZIDE | 80MG | TABLET | Discontinued | 2017-07-18 | 2017-12-02 | 16126 |
| SANDOZ GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2024-12-06 | 2024-12-07 | 245021 |
| SANDOZ GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2024-12-06 | 2024-12-07 | 245024 |
| SANDOZ GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2024-12-06 | 2024-12-07 | 245027 |
| SANDOZ GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2024-12-06 | 2024-12-07 | 245030 |
Showing 1 to 8 of 8